Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-114096·SATTERFIELD THOMAS A JR
Schedule 13G ownership disclosure
ENVVENO MEDICAL CORPORATION
Common Stock, $0.00001 par value per share · CUSIP: 29415J106
Event date: 2025-11-14
- Filing-level shares
- 1,822,500.00
- Percent of class
- 9.0%
- Thomas A. Satterfield, Jr.
Shares: 1,822,500.00 · Class: 9.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-114096
- Form type
- SCHEDULE 13G
- Filer
- SATTERFIELD THOMAS A JR
- CIK
- CIK 1132317
- Filed
- Nov 19, 2025
- Reporting period
- Nov 14, 2025
- Description
- Schedule 13G beneficial ownership